PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product 25-hydroxyvitamin D testing - Market size and forecast 2018-2023 1,25-dihydroxyvitamin D testing - Market size and forecast 2018-2023 Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER Market segmentation by end-user PART 09: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES Market drivers Market challenges PART 12: MARKET TRENDS Increasing number of infections and autoimmune diseases Growing number of strategic developments by vendors Innovative product offerings by vendors PART 13: VENDOR LANDSCAPE Overview Landscape disruption PART 14: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Abbott Laboratories bioMérieux SA Danaher Corp. F. Hoffmann-La Roche Ltd. Siemens Healthcare GmbH PART 15: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 16: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: -hydroxyvitamin D testing - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Parameters for 25-hydroxyvitamin serum concentrations Exhibit 22: -hydroxyvitamin D testing - Year-over-year growth 2019-2023 (%) Exhibit 23: ,25-dihydroxyvitamin D testing - Market size and forecast 2018-2023 ($ millions) Exhibit 24: ,25-dihydroxyvitamin D testing - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by product Exhibit 26: Customer landscape Exhibit 27: Global vitamin D testing market share by end-users 2018 Exhibit 28: Market share by geography 2018-2023 (%) Exhibit 29: Geographic comparison Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Recommended dietary allowance for vitamin D by age and gender Exhibit 32: North America - Year-over-year growth 2019-2023 (%) Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Europe - Year-over-year growth 2019-2023 (%) Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Asia - Year-over-year growth 2019-2023 (%) Exhibit 37: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 38: ROW - Year-over-year growth 2019-2023 (%) Exhibit 39: Key leading countries Exhibit 40: Market opportunity Exhibit 41: Impact of drivers and challenges Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Abbott Laboratories - Vendor overview Exhibit 48: Abbott Laboratories - Business segments Exhibit 49: Abbott Laboratories - Organizational developments Exhibit 50: Abbott Laboratories - Geographic focus Exhibit 51: Abbott Laboratories - Segment focus Exhibit 52: Abbott Laboratories - Key offerings Exhibit 53: bioMérieux SA - Vendor overview Exhibit 54: bioMérieux SA - Business segments Exhibit 55: bioMérieux SA - Organizational developments Exhibit 56: bioMérieux SA - Geographic focus Exhibit 57: bioMérieux SA - Key offerings Exhibit 58: Danaher Corp. - Vendor overview Exhibit 59: Danaher Corp. - Business segments Exhibit 60: Danaher Corp. - Organizational developments Exhibit 61: Danaher Corp. - Geographic focus Exhibit 62: Danaher Corp. - Segment focus Exhibit 63: Danaher Corp. - Key offerings Exhibit 64: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 65: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 66: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 67: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 68: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 69: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 70: Siemens Healthcare GmbH - Vendor overview Exhibit 71: Siemens Healthcare GmbH - Business segments Exhibit 72: Siemens Healthcare GmbH - Organizational developments Exhibit 73: Siemens Healthcare GmbH - Geographic focus Exhibit 74: Siemens Healthcare GmbH - Segment focus Exhibit 75: Siemens Healthcare GmbH - Key offerings Exhibit 76: Validation techniques employed for market sizing Exhibit 77: Definition of market positioning of vendors

Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., and Siemens Healthcare GmbH.